Evidence map›Paper›PMID 33631079›Full record

ArticleAnnals of the American Thoracic Society2021

Defining Resilience to Smoking-related Lung Disease: A Modified Delphi Approach from SPIROMICS.

Anita L Oh, Richard A Mularski, Igor Barjaktarevic, R Graham Barr, Russell P Bowler, Alejandro P Comellas, Christopher B Cooper, Gerard J Criner, MeiLan K Han, Nadia N Hansel and 9 more

Registry-linked trialOpen access · greenAbstract read
In one paragraph

Article in Annals of the American Thoracic Society, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01969344 (Subpopulations and Intermediate Outcome Measures in COPD Study), which is not on this map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01969344 active not recruitingnot on this map

Subpopulations and Intermediate Outcome Measures in COPD Study

TypeobservationalSponsorUniversity of North Carolina, Chapel HillRan2010 to 2031Enrolled2,981ConditionsCOPD, Chronic Obstructive Pulmonary Disease, Chronic Bronchitis, Emphysema
3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Investigating human lung resilience, its evolutionary history and its relation to COPD.American journal of physiology. Lung cellular and molecular physiology · 2026
    Review
  2. Article
  3. Article
  4. Toward a solution-focused addiction science.Frontiers in public health · 2025
    Article
  5. Article
  6. Defining Resilience: A Critical Step to Promote Respiratory Health.Annals of the American Thoracic Society · 2021
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors at 13 institutions in 1 country.

Anita L OhDivision of Pulmonary, Critical Care, and Sleep Medicine, University of California San Francisco, San Francisco, California.
Richard A MularskiThe Center for Health Research, Kaiser Permanente Northwest, Portland, Oregon.
Igor BarjaktarevicDivison of Pulmonary and Critical Care, David Geffen School of Medicine, University of California, Los Angeles, California.
R Graham BarrDepartment of Medicine and Epidemiology, Columbia University Medical Center, New York, New York.
Russell P BowlerDivision of Pulmonary, Critical Care, and Sleep Medicine, National Jewish Health, Denver, Colorado.
Alejandro P ComellasDivision of Pulmonary, Critical Care, and Occupational Medicine, University of Iowa Carver College of Medicine, Iowa City, Iowa.ORCID 0000-0003-1521-7520
Christopher B CooperDivison of Pulmonary and Critical Care, David Geffen School of Medicine, University of California, Los Angeles, California.
Gerard J CrinerDivision of Thoracic Medicine and Surgery, Temple University, Philadelphia, Pennsylvania.
MeiLan K HanDivision of Pulmonary and Critical Care Medicine, University of Michigan, Ann Arbor, Michigan.
Nadia N HanselDivision of Pulmonary and Critical Care Medicine, Johns Hopkins University, Baltimore, Maryland.
Eric A HoffmanDepartment of Radiology, University of Iowa, Iowa City, Iowa.
Richard E KannerDivision of Respiratory, Critical Care, and Occupational Pulmonary Medicine, University of Utah, Salt Lake City, Utah.
Jerry A KrishnanDivision of Pulmonary, Critical Care, Sleep, and Allergy Medicine, University of Illinois at Chicago, Chicago, Illinois.ORCID 0000-0001-5525-4778
Robert PaineDivision of Respiratory, Critical Care, and Occupational Pulmonary Medicine, University of Utah, Salt Lake City, Utah.
Trisha M ParekhDivision of Pulmonary, Allergy and Critical Care Medicine, University of Alabama at Birmingham, Birmingham, Alabama; and.
Stephen P PetersPulmonary, Critical Care, Allergy, and Immunologic Medicine, Wake Forest School of Medicine, Winston-Salem, North Carolina.
Stephanie A ChristensonDivision of Pulmonary, Critical Care, and Sleep Medicine, University of California San Francisco, San Francisco, California.
Prescott G WoodruffDivision of Pulmonary, Critical Care, and Sleep Medicine, University of California San Francisco, San Francisco, California.
SPIROMICS Smoking Resilience Group
University of California, San Francisco · USUniversity of California, Los Angeles · USUniversity of Iowa · USUniversity of Utah · USColumbia University Irving Medical Center · USJohns Hopkins University · USKaiser Permanente Center for Health Research · USNational Jewish Health · USTemple University · USUniversity of Alabama at Birmingham · USUniversity of Illinois Chicago · USUniversity of Michigan · USWake Forest University · US

Funding

Pulmonary Toxicology Facility CoreP30ES005605 · NIEHS · UNIVERSITY OF IOWA · PI Jong Sung Kim · 1990 to 2026
$40.5M
SPIROMICS II: Biological underpinnings of COPD heterogeneity and progressionU01HL137880 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI WOODRUFF, PRESCOTT G · 2017 to 2021
$27.9M
SPIROMICS GIC SupportU24HL141762 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI COUPER, DAVID J, O'NEAL, WANDA K · 2018 to 2022
$7.2M
Mentoring Research in Precision Medicine for Lung DiseaseK24HL137013 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI PRESCOTT G WOODRUFF · 2017 to 2026
$1.2M
Identifying the Th2 endotype in COPD: clinical and pathologic implicationsK23HL123778 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CHRISTENSON, STEPHANIE A · 2015 to 2019
$847k
Development of a Community Health Worker-Led Stress Reduction Intervention for Low-Income COPD PatientsK23HL153672 · NHLBI · UNIVERSITY OF TEXAS AT AUSTIN · PI PAREKH, TRISHA M · 2020 to 2024
$840k
Investigating the Resilient SmokerF32HL149329 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI OH, ANITA · 2019 to 2021
$255k
NHLBI NIH HHS F32 HL149329NHLBI NIH HHS HHSN268200900013CNHLBI NIH HHS HHSN268200900014CNHLBI NIH HHS HHSN268200900015CNHLBI NIH HHS HHSN268200900016CNHLBI NIH HHS HHSN268200900017CNHLBI NIH HHS HHSN268200900018CNHLBI NIH HHS HHSN268200900019CNHLBI NIH HHS HHSN268200900020CNHLBI NIH HHS K23 HL123778NHLBI NIH HHS K23 HL153672NHLBI NIH HHS K24 HL137013NHLBI NIH HHS L30 HL154180NHLBI NIH HHS U01 HL137880NHLBI NIH HHS U24 HL141762NIEHS NIH HHS P30 ES005605
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Pulmonary Disease, Chronic ObstructiveSmokingForced Expiratory VolumeHumansLungSpirometrybiomarkerschronic obstructive pulmonary diseaseconsensus developmentsmokingspirometry

Identifiers

PMID33631079
PMCPMC8641833
OpenAlexW3130843653

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.